NCT03219840View on ClinicalTrials.gov

Cetylpyridium Chloride (CPC) Based Chewing Gum and Gingivitis

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

October 18, 2017

Primary Completion Date

September 8, 2018

Study Completion Date

September 8, 2018

Conditions
GingivitisPlaque, DentalPeriodontal Diseases
Interventions
DRUG

Cetylpyridinium Chloride (CPC) 0.09% + Xylitol chewing gum

All subjects will be instructed to chew four times a day, for at least 60 seconds, after which they expectorated.

DRUG

Xylitol only chewing gum

All subjects will be instructed to chew four times a day, for at least 60 seconds, after which they expectorated.

Trial Locations (1)

77054

The University of Texas Health Science Center at Houston, Houston

All Listed Sponsors
collaborator

CONFADENT Oral Technology, Kiss Industries LLC

UNKNOWN

lead

The University of Texas Health Science Center, Houston

OTHER

NCT03219840 - Cetylpyridium Chloride (CPC) Based Chewing Gum and Gingivitis | Biotech Hunter | Biotech Hunter